S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways.
about
S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@en
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@nl
type
label
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@en
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@nl
prefLabel
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@en
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@nl
P2093
P2860
P1476
S100A9 aggravates bleomycin-in ...... RK1/2 MAPK and NF-κB pathways.
@en
P2093
Cheng Zhao
Dandan Wang
Hejian Zou
Jiucun Wang
Lingyun Sun
Xiaoxia Zhu
Zhiyong Chen
P2860
P304
P356
10.22038/IJBMS.2018.19987.5255
P50
P577
2018-02-01T00:00:00Z